Skip to content
Tagged COVID-19 Biotechnology SARS-CoV-2 Life Science cancer CORONAVIRUS pandemic
BioXone

BioXone

rethinking future

June 6, 2025
  • About
  • BiotechTodayNews
    • IndiaWeekly Biotech News of India
    • WorldWeekly Biotech News of The World
  • DNA-TalesArticles
    • BiotechnopediaInteresting articles written by BioXone members and associates.
    • Scientists’ CornerArticles from the pioneers of Biotechnology.
    • Cellular CommunicationInterview of greatest researchers’ in the field.
  • Myth-LysisFact Check
  • Signalling PathwayCareer related updates
    • ExaminationsExamination related articles.
    • Job and InternshipJobs and Internship related articles.
  • Courses
  • Contact

Most Viewed This Week

October 17, 2023October 16, 2023

The Corrosion Prediction from the Corrosion Product Performance

1
October 1, 2023September 30, 2023

Nitrogen Resilience in Waterlogged Soybean plants

2
September 28, 2023September 28, 2023

Cell Senescence in Type II Diabetes: Therapeutic Potential

3
September 26, 2023September 25, 2023

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

4
September 25, 2023September 25, 2023

AI Literacy in Early Childhood Education: Challenges and Opportunities

5
September 22, 2023October 1, 2023

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

6

Search Field

Subscribe Now

  • Home
  • FDA

Tag: FDA

  • BiotechToday
  • World

COVID-19 vaccine for children: Pfizer shows progress!

BioTech Today November 22, 2021November 22, 2021 1

Ananya Ghosal, MAKAUT(WB) COVID-19 vaccine is still a dream for children under 12. Although children are not at risk of COVID-19 like adults, their reports are still positive. The delta variant and reopening of schools combined and resulted in a keen rise in pediatric COVID-19 cases that is related to the records in the pandemic. […]

Read More
  • BiotechToday
  • World

First interchangeable biosimilar insulin for diabetic patients

bioxone August 2, 2021August 1, 2021 3

Komal Bavaskar, Mumbai university Diabetes affects around 422 million people globally, with the majority residing in low- and middle-income countries, and diabetes is directly responsible for 1.6 million mortality per year. Diabetes has already been diagnosed in over 30 million people in India. What is diabetes? It is a metabolic disorder that results in elevated […]

Read More
  • BiotechToday
  • World

Cervical cancer screening task: ASCCP

bioxone August 2, 2021August 1, 2021 1

Ananya Ghosal, MAKAUT(WB) Guidelines of ASCCP The American cancer society (ASC) released the screening guideline for cervical cancer. The guideline initiates a shift in practice to Human papilloma Virus (HPV) screening at the age of 25-65 years in people with the cervix. The American Society for colposcopy and cervical pathology (ASCCP) acknowledges the risk and […]

Read More
  • BiotechToday
  • World

Treatment of Lymphoma in Dogs- Fully granted by FDA for the first time

bioxone July 29, 2021July 28, 2021 6

Nimrit Palan, Mumbai university One of the most prevalent types of cancer in dogs is lymphoma. It is made up of immune system cells called lymphocytes that circulate through the bloodstream. As a result, lymphoma is often seen as a systemic disease that requires systemic treatment. Dogs with lymphoma have a life expectancy of 1-2 […]

Read More
  • BiotechToday
  • World

J&J COVID-19 vaccine: A potential disaster for humans

bioxone July 14, 2021July 14, 2021 1

Saptaparna Dasgupta, Bennett University The COVID-19 vaccine has been created as an emergency vaccine, based on several strategies, such as mRNA vaccine, inactivated virus vaccine, etc. The other vaccines having cleared the clinical trials have passed on to the mass population vaccination drives, without any reported risk factors, yet. However, Johnson and Johnson’s COVID 19 […]

Read More
  • BiotechToday
  • World

Vaccination update: Pfizer allowed for emergency use in adolescents

bioxone May 12, 2021May 12, 2021 1

Camelia Bhattacharyya, Amity University Kolkata Amongst all the most awaited news, the updates on vaccination are the ones most wanted these days. People have finally become aware of the need for vaccination, and the number of anti-vaxxers has reduced. This has helped the medical community level up their reviews on saving lives, and information regarding […]

Read More
  • BiotechToday
  • World

Drug to treat African trypanosomiasis (sleeping sickness) disease discovered

bioxone February 8, 2021February 7, 2021 3

Husna, Amity University Kolkata African trypanosomiasis, also known as sleeping sickness is a disease fatal to both humans and animals. It is transmitted to humans and animals by the tsetse fly.  A vaccine for protection from this disease hasn’t been discovered making its transmission control rely on eliminating the tsetse fly population. Neurotoxic insecticides and […]

Read More
  • BiotechToday
  • World

Moderna’s mRNA–1273 granted emergency use authorization by FDA

bioxone December 28, 2020December 28, 2020 2

Prama Ghosh, Amity University Kolkata The Food and Drug Administration announced granted emergency use authorization to Moderna’s mRNA–1273, it’s COVID-19 vaccine for use in individuals 18 and older Friday night, the second vaccination against the coronavirus in the United States one week after the agency authorized a similar vaccine from Pfizer and BioNTech. Moderna’s vaccine […]

Read More
  • BiotechToday
  • World

Invisible cancer risk in talc-based cosmetics

bioxone December 4, 2020December 4, 2020 1

Devyani Goswami, Amity University Kolkata More than 60% of cosmetics products are made up of talc to enhance the quality of the product. A two years (2018-2020) study concluded that every talc-based cosmetics products have a little amount of asbestos in them which can cause cancer, as many complaints were made stating women suffering from […]

Read More
  • BiotechToday
  • World

ENGINEERED ONCOLYTIC ADENOVIRUS TO TREAT METASTATIC CANCER

bioxone December 2, 2020December 2, 2020 4

Husna, Amity University Kolkata Oncolytic viruses are genetically engineered for the destruction of cancer or tumour-causing cells specifically. They’re delivered for treatment inside the body via intravenous injection. In 2015, one such oncolytic virus was approved by the FDA for treating skin cancer, melanoma. A major obstacle in the application of oncolytic adenoviruses is that […]

Read More

Posts navigation

1 2

Breaking News

The Corrosion Prediction from the Corrosion Product Performance

Nitrogen Resilience in Waterlogged Soybean plants

Cell Senescence in Type II Diabetes: Therapeutic Potential

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

AI Literacy in Early Childhood Education: Challenges and Opportunities

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

Exogenous Klotho as a Cognition Booster in Aging Primates

Terms and Conditions
Shipping and Delivery Policy
Cancellation and Refund Policy
Contact Us
Privacy Policy